Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone

Olympus introduces new precise quantitative assay for Paracetamol

Olympus Life Science Europa - Diagnostics : 22 July, 2008  (New Product)
A new quantitative assay for Paracetamol (Acetaminophen) has been introduced by Olympus that demonstrates greater stability than previously available tests.
With improved on-board instrument and calibration stability, the new Olympus Enzymatic Paracetamol test requires fewer calibration episodes and will reduce wastage, so saving time and money.

The new Olympus Assay utilises an enzymatic procedure and has a very broad range of detection (5 – 2500 µmol/L or 0.76 – 378 mg/L) with precision across this range. The stability of the test is demonstrated by an on-board stability of 14 days, plus a calibration interval of seven days. Consequently, this enables reliable, calibration-free operation for out of hours Paracetamol overdose detection in human serum and plasma.

External Quality Assessment schemes have demonstrated correlation of the new Olympus Paracetamol test with other leading reagents.

The complete Olympus Paracetamol kit includes all necessary calibration material, buffers and reagents. The calibrator is completely stable unopened up to the stated expiry date, once opened it remains stable for 30 days.

“Early detection of Paracetamol overdose is crucial, as the initiation of therapy within 16 hours of ingestion reduces the potential for hepatic injury and decreases the rate of mortality”, explained Chris Jones, Olympus product manager (Clinical Chemistry and Patient Safety). “We are, therefore, very pleased to be able to meet our customers’ requirements for simple and reliable Paracetamol measurement by launching our new Enzymatic Paracetamol Test.”
Bookmark and Share
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   Â© 2012
Netgains Logo